Detalhe da pesquisa
1.
A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: a gynecologic oncology group study.
Gynecol Oncol
; 116(3): 332-4, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19922989
2.
Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
J Clin Oncol
; 22(15): 3113-9, 2004 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15284262
3.
Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
Am J Clin Oncol
; 25(6): 557-60, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12477997
4.
Activity of paclitaxel as second-line chemotherapy in endometrial carcinoma: a Gynecologic Oncology Group study.
Gynecol Oncol
; 88(3): 277-81, 2003 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12648575
5.
Phase II evaluation of oxaliplatin in previously treated squamous cell carcinoma of the cervix: a gynecologic oncology group study.
Gynecol Oncol
; 90(1): 177-80, 2003 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-12821360